reports
- GlobalData Healthcare Department
ImmunoClin Corp (IMCL) - Financial Analysis Review
ImmunoClin Corp (IMCL) - Financial Analysis Review Summary ImmunoClin Corp (ImmunoClin) formerly Pharma Investing News, Inc focuses on the immunology research and development to offer services to pharmaceutical, biotechnology and food industries. The company’s product portfolio comprises Multi-Variant Atherosclerosis Risk Assessment (MARA), Genetic Alzheimer’s Risk Discovery, a genetic test for multiple genetic polymorphisms; PRIMALEUKIN, an anti-infective therapy; and DACTELLIGENCE. Glob...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.